i3 Innovus was pleased to sponsor a leading-edge educational symposium at the ISPOR 10th Annual European Congress in Dublin, Ireland. The panel included a renowned group of international stakeholders discussing a theme central to our industry: the need to continually demonstrate the value of future innovations.

CAN WE AFFORD TO PAY FOR INNOVATION?
DELIVERING COST-EFFECTIVE HEALTH CARE AND MAXIMIZING HEALTH WHILE STIMULATING CONTINUED RESEARCH AND DEVELOPMENT.

This symposium brought together the perspectives of academics and the pharmaceutical industry to discuss how the development of innovations in health care represents an important component of the current therapeutic arsenal, and how budget constraints create tensions between delivering cost-effective health care, maximizing health, and stimulating continued research and development.

Symposium Chair
Bengt Jönsson, DPhil, Professor, Health Economics, Stockholm School of Economics and Principal Consultant, i3 Innovus

Speakers

Alistair McGuire, DPhil, Professor of Health Economics, London School of Economics, Health and Social Care and Principal Consultant, i3 Innovus
Peter Hertzman, PhD, Director Corporate Affairs, Amgen Nordic
Thomas B. Cueni, Secretary General, Interpharma AG, Chair of European
Federation of Pharmaceutical Industries and Associations Economic and Social Policy Committee (ESPC)

This information was originally presented on October 23, 2007.